BioBonds Use Wall Street Tools to Fund Medical Research
Karen Petrou invented a new funding model for curing blindness. Proposed legislation aims to apply it to medical research more generally. (Source: NYT Health)
Source: NYT Health - July 12, 2021 Category: Consumer Health News Authors: Ephrat Livni Tags: Clinical Trials Drugs (Pharmaceuticals) Law and Legislation Petrou, Karen Shaw Research Lobbying and Lobbyists Health and Human Services Department Rush, Bobby L Fitzpatrick, Brian K (1973- ) Source Type: news

Are you overusing hand sanitizer? Doctors say this could lead to blindness and even death
(Natural News) Medical experts are urging caution and telling Americans not to overuse hand sanitizer, especially if it was not manufactured in the United States. This is because the hand sanitizer might contain one toxic chemical: methanol. Hand sanitizers in the U.S. are banned from using methanol. The Food and Drug Administration (FDA) noted that it is... (Source: NaturalNews.com)
Source: NaturalNews.com - July 8, 2021 Category: Consumer Health News Source Type: news

Artificial intelligence provides faster diagnosis for debilitating blistering disease
(University of Groningen) Scientists at the University of Groningen have trained an Artificial Intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita. The pattern is characteristic of a specific variant of the disease which can cause scarring of the skin and mucous membranes, and may lead to blindness. The new system is easy to use and is better than most doctors in making the diagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2021 Category: International Medicine & Public Health Source Type: news

Hand sanitizer will remain in US households post-pandemic but doctors warn overuse can be dangerous
Experts fear that overuse of hand sanitizer, specifically those that use methanol, can be dangerous over time. Methanol, which is banned in the U.S., can cause blindness or death. (Source: the Mail online | Health)
Source: the Mail online | Health - July 7, 2021 Category: Consumer Health News Source Type: news

Assessing knowledge and practice about eye injuries first aid, with awareness about the importance of early management among general population in Asser Region, 2020 - Dhabaan WA, Almutairi KH, Alzahrani AA, Almutlaq AH, Jali Asiri AAH, Hasan Alshahrani RS, Hadi Jali MA, Alqahtani AMA.
BACKGROUND: Eye injury is a leading cause of monocular blindness and is second only to cataract as the commonest cause of visual impairment. Injury is the commonest reason for eye-related emergency department visits. AIM: To assess population aware... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Investor Update - June 28, 2021 Category: Pharmaceuticals Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Media News - June 28, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)
Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Neovascular AMD is a leading cause of blindness for people aged 60 and over and impacts approximatel y 20 million people worldwide.1,2,3 If approved, PDS would be a first-of-its-kind therapeutic approach, offering people living with nAMD an alternative to frequent eye i...
Source: Roche Investor Update - June 24, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)
Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Neovascular AMD is a leading cause of blindness for people aged 60 and over and impacts approximatel y 20 million people worldwide.1,2,3 If approved, PDS would be a first-of-its-kind therapeutic approach, offering people living with nAMD an alternative to frequent eye i...
Source: Roche Media News - June 24, 2021 Category: Pharmaceuticals Source Type: news

Recycling of the eye's light sensors is faulty in progressive blindness of older adults
(University of Maryland School of Medicine) With the National Eye Institute reporting that about 11 million older adults in the U.S. endure a condition that leads to progressive blindness, known as age-related macular degeneration, University of Maryland School of Medicine (UMSOM) researchers are starting to understand what goes wrong in the disease, in order to develop new therapies to treat it. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 23, 2021 Category: International Medicine & Public Health Source Type: news

Inflammation of the eye after drug withdrawal in children with arthritis
(European Alliance of Associations for Rheumatology) Uveitis is an inflammation of the eye and is a common extra-articular manifestation associated with juvenile idiopathic arthritis (JIA). It can cause vision-threatening complications, and if left uncontrolled may even lead to blindness. The majority of children develop uveitis within the first 2 years after arthritis symptom onset, but it can continue into adulthood. This is the first prospective study to analyzed uveitis risk after drug withdrawal, and found that uveitis relapses are common. Rheumatologists and ophthalmologists should be aware and should plan for uveiti...
Source: EurekAlert! - Medicine and Health - June 18, 2021 Category: International Medicine & Public Health Source Type: news

Ultra-thin film could one day turn regular glasses into night vision goggles, researchers say
Developed by Australian and European researchers, the film works by converting infrared light into light visible to the human eyeA transparent metallic film allowing a viewer tosee in the dark could one day turn regular spectacles into night vision googles.The ultra-thin film, made of a semiconductor called gallium arsenide, could also be used to develop compact and flexible infrared sensors, scientists say.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 15, 2021 Category: Science Authors: Donna Lu Tags: Science Blindness and visual impairment Health Medical research Source Type: news

2nd progressive vision loss drug by Biogen fails in late-stage trial
Another gene therapy for progressive vision loss developed by Biogen Inc. (Nasdaq: BIIB) has failed in a late-stage clinical trial, the company announced Monday. The drug, designed to target the rare genetic blindness disorder choroideremia, did not show significant benefit 12 months after treatment in a Phase 3 study involving 169 men with the disease. Biogen says it will evaluate the complete dataset before deciding on next steps for the drug's developme nt. This is the second failure in as many… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 14, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

Touchless technology could enable early detection and treatment of eye diseases that cause blindness
(University of Waterloo) A new non-contact laser imaging system developed by engineering researchers at the University of Waterloo, is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

CORRUPTION: Covid-19 mRNA vaccines instruct your cells to CLOG YOUR BLOOD with protein prions that inflame the heart while suffocating the brain
(Natural News) Adverse events and side effects from Covid vaccines include heart inflammation, blood clots, vision changes (blindness), abnormal or total loss of ability to smell and taste, confusion, balance issues, passing out, severe headache and dysphasia. Coincidentally, these are all symptoms of a transient ischemic attack (mini-stroke or ‘TIA’) that occurs when blood flow... (Source: NaturalNews.com)
Source: NaturalNews.com - June 8, 2021 Category: Consumer Health News Source Type: news

AI could soon tell you, how often to see the eye doctor
(Inselspital, Bern University Hospital) Three of the most common chronic eye conditions require regular medical check-ups and injections into the eye by ophthalmology specialists to keep looming blindness at bar. A study by the University of Bern and the Inselspital in collaboration with an AI in eyecare startup now demonstrates that patients' individual ideal frequency for these visits can quite accurately be predicted by machine learning - yielding a threefold benefit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2021 Category: International Medicine & Public Health Source Type: news

Epidemiological findings of childhood ocular trauma in a public hospital in Colombia - D'Antone V, Fl órez DCP, García CJL, Manrique FDMC, Barbosa NL.
BACKGROUND: Eye injury is a serious worldwide public health problem that may cause blindness. In children, blindness has functional impact and psychosocial implications. As indicated in many worldwide studies, identification of risk factors associated with... (Source: SafetyLit)
Source: SafetyLit - June 7, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

West Africa: How the Gambia Beat an Infection That Causes Blindness
[The Conversation Africa] The government of The Gambia recently announced that the country had eliminated trachoma, a highly contagious eye disease, after years of hard work by health workers, nongovernmental organisations (NGOs) and communities. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 7, 2021 Category: African Health Source Type: news

Kenya: Blindness, Memory Loss Risk for Diabetic Covid Patients
[Nation] Diabetic patients who got severely ill from Covid-19 and have recovered, or are infected with the virus, are at a higher risk of an infection that can lead to blindness and memory loss. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 29, 2021 Category: African Health Source Type: news

Medically Minded Hand Sanitizer – Nationwide Recall Expansion Due to The Presence of Undeclared Methanol
This recall has been initiated due to the presence of undeclared Methanol. Use of or consumption of this product can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma& or permanent damage to the nervous system or death. Although all persons using these produc (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 25, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

A First: Blind Man's Sight Restored With Optogenetic Therapy A First: Blind Man's Sight Restored With Optogenetic Therapy
Combining gene therapy with light-stimulating goggles enabled a patient with a 40-year history of blindness caused by retinitis pigmentosa to regain partial sight.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - May 25, 2021 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

A Blind Patient Regained Partial Sight in a Breakthrough Study, Offering Hope to Millions
The darkness descends slowly for people with retinitis pigmentosa (RP), a degenerative eye disease that affects 2 million people worldwide. The condition is typically diagnosed in childhood or adolescence, but it can take until middle age before a person’s vision has deteriorated severely enough that they are fully or effectively blind. When the lights finally do go out, however, they stay out. Or that’s the way things used to be. In a breakthrough study published today in Nature Medicine, investigators report a relatively simple yet remarkably effective way to restore partial vision to RP patients—one th...
Source: TIME: Health - May 24, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized embargoed study Innovation Source Type: news

A Blind Patient Regained Partial Sight in a Breakthrough Study, Offering Hope to Millions
The darkness descends slowly for people with retinitis pigmentosa (RP), a degenerative eye disease that affects 2 million people worldwide. The condition is typically diagnosed in childhood or adolescence, but it can take until middle age before a person’s vision has deteriorated severely enough that they are fully or effectively blind. When the lights finally do go out, however, they stay out. Or that’s the way things used to be. In a breakthrough study published today in Nature Medicine, investigators report a relatively simple yet remarkably effective way to restore partial vision to RP patients—one th...
Source: TIME: Science - May 24, 2021 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized embargoed study Innovation Source Type: news

Blind Man's Sight Partially Restored with'Optogenetics' Gene Therapy
Using a technique called optogenetics, researchers added light-sensitive proteins to the man ’s retina, giving him a blurry view of objects. (Source: NYT Health)
Source: NYT Health - May 24, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: Eyes and Eyesight Research Blindness Science and Technology Brain Genetic Engineering Source Type: news

Blind man has sight partly restored after pioneering treatment
Man regains ability to recognise objects in first example of successful optogenetic therapy in humansA blind man has had his sight partly restored after a form of gene therapy that uses pulses of light to control the activity of nerve cells – the first successful demonstration of so-called optogenetic therapy in humans.The 58-year-old man, from Brittany in northern France, was said to be “very excited” after regaining the ability to recognise, count, locate and touch different objects with the treated eye while wearing a pair of light-stimulating goggles, having lost his sight after being diagnosed with r...
Source: Guardian Unlimited Science - May 24, 2021 Category: Science Authors: Linda Geddes Science correspondent Tags: Neuroscience Blindness and visual impairment Medical research Health Society Disability Source Type: news

Transient total blindness associated with alcoholic ketoacidosis - Sato H, Kyan R, Kamada C, Kaku M, Sato S, Tawara T, Sakawaki E, Sakawaki S, Takeyama Y.
We report the case of... (Source: SafetyLit)
Source: SafetyLit - May 22, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Does age-related macular degeneration (AMD) treatment influence patient falls and mobility? A systematic review - Garrigan H, Hamati J, Lalakia P, Frasso R, Salzman B, Hyman L.
PURPOSE: Age-related macular degeneration (AMD), a leading cause of irreversible blindness, increases fall risk through impaired central vision. Falls place an enormous economic burden on healthcare systems. We hypothesized that AMD treatments may reduce p... (Source: SafetyLit)
Source: SafetyLit - May 20, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Uses novel, mutation agnostic optogenetics approach to restore vision in underserved forms of blindness Company backed by leading life science investors including Octagon Capital, Samsara BioCapital and Casdin Capital, along with founding investors Atla... Biopharmaceuticals, Ophthalmology, Venture Capital Vedere Bio II, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2021 Category: Pharmaceuticals Source Type: news

Estimated 1 Million Individuals Living With Blindness in the U.S.
MONDAY, May 17, 2021 -- Roughly 7.1 million people are living with visual acuity loss in the United States; and of these individuals, nearly 1.1 million are living with blindness, according to a meta-analysis published online May 13 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2021 Category: Pharmaceuticals Source Type: news

An amazing revelation about the GOP's willful blindness on Donald Trump
When I read these lines in a Washington Post profile of Wyoming Rep. Liz Cheney over the weekend, I gasped: (Source: Reuters: Health)
Source: Reuters: Health - May 10, 2021 Category: Consumer Health News Source Type: news

Covid-sparked fungal infection assuming epidemic proportions
India News: Triggered by coronavirus, mucormycosis, which has a mortality rate of over 50% and can lead to blindness, is sweeping... (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2021 Category: Consumer Health News Source Type: news

Ophthalmologists now ethically obligated to denounce covid-19 vaccines, as 20,000 new eye disorders are reported
(Natural News) In just a few months, the World Health Organization received approximately 20,000 reports of new eye disorders that occurred post covid-19 vaccination. These reports include 303 cases of blindness and 1,625 cases of visual impairment! The European drug monitoring agency had never recorded such a severe spike in eye injuries until after the... (Source: NaturalNews.com)
Source: NaturalNews.com - May 5, 2021 Category: Consumer Health News Source Type: news

CHMP recommends EU approval of Roche ’s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)
Basel, 23 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ENSPRYNG® (satralizumab) as the first subcutaneous treatment option for adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spe ctrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). AQP4-IgG are present in around 70-80% of people with NMOSD, who tend to experience a more severe disease course.NMOS...
Source: Roche Media News - April 23, 2021 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)
Basel, 23 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ENSPRYNG® (satralizumab) as the first subcutaneous treatment option for adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spe ctrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). AQP4-IgG are present in around 70-80% of people with NMOSD, who tend to experience a more severe disease course.NMOS...
Source: Roche Investor Update - April 23, 2021 Category: Pharmaceuticals Source Type: news

Disability in Goma. The Power of Staying Together Against Covid-19, War, and Stigma
Credit: Elena L. PasquiniBy Elena L. PasquiniROME, Apr 22 2021 (IPS) Sylvain Kakule Kadjibwami lost the use of his legs during one of those ambushes that bloodlessly bleed North Kivu. “When I was shot, I thought it was the end of my life, but when I shared it with other disabled people, I discovered that life is still possible,” he said. Now it is Covid-19 that risks destroying the dreams of Sylvain, a small trader from Goma, a city whose roads are volcanic rock-ridden screes where pick-ups trudge. Those who walk face the risk of falling at every step. However, for those who cannot, the same roads can become tr...
Source: IPS Inter Press Service - Health - April 22, 2021 Category: International Medicine & Public Health Authors: Elena Pasquini Tags: Africa Aid Armed Conflicts Crime & Justice Economy & Trade Featured Food & Agriculture Headlines Health Human Rights Humanitarian Emergencies Multimedia TerraViva United Nations Video Source Type: news

Gambia: Govt Eliminates Trachoma, a Leading Cause of Blindness Worldwide
[Thomson Reuters Foundation] Addis Ababa -- Small West African nation follows Ghana in successfully eradicating the painful eye disease, which still affects people in more than 40 countries (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 22, 2021 Category: African Health Source Type: news

The Gambia becomes second African state to end trachoma
Health workers spent years targeting agonising and blinding eye disease, which was rife in rural areasThe Gambia has become the second country in Africa to eliminate trachoma, one of the leading causes of blindness.The achievement, announced by the World Health Organization on Tuesday, came after decades of work on the disease, which has damaged the sight ofabout 1.9 million people worldwide. Ghana was thefirst country in Africa to eliminate the disease in 2018.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 22, 2021 Category: Science Authors: Kaamil Ahmed Tags: Global health The Gambia World Health Organization Global development Society Africa World news Infectious diseases Science Source Type: news

Gene therapy shows promise in initial trial for patients with childhood blindness
(University of Pennsylvania School of Medicine) A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2021 Category: International Medicine & Public Health Source Type: news

Nepal’s God of Sight eye doctor to expand work beyond border
Nepal’s “God of Sight” eye doctor renowned for his innovative and inexpensive cataract surgery for the poor is taking his work beyond the Himalayan mountains so there is no more unnecessary blindness in the world (Source: ABC News: Health)
Source: ABC News: Health - April 8, 2021 Category: Consumer Health News Tags: Health Source Type: news

LSU Health New Orleans study discovers source of Zika neurodevelopmental defects
(Louisiana State University Health Sciences Center) A study led by Edward Wojcik, PhD, Associate Professor of Biochemistry& Molecular Biology at LSU Health New Orleans School of Medicine, identified how microcephaly (abnormally small heads) and blindness may develop in Zika-infected fetuses, as well as a new way to potentially prevent these neurodevelopmental defects. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 6, 2021 Category: Infectious Diseases Source Type: news

New perspective to understand and treat a rare calcification disease
(E ö tv ö s Lor á nd University (ELTE), Faculty of Science) As part of an international collaboration, researchers from ELTE E ö tv ö s Lor á nd University developed a new animal model to study a rare genetic disease that can lead to blindness at the age of 40-50. The new model could open up new perspectives in our understanding of this metabolic disease and will also help to identify new potential drug candidates. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2021 Category: International Medicine & Public Health Source Type: news

Marijuana for glaucoma treatment: a recipe for disaster - Daga FB, Almeida I, Prata TS, Paranhos AJ.
Glaucoma is the leading cause of irreversible blindness worldwide(1). It occurs more frequently in elderly individuals, but it can also develop in young adults, children, and newborns. Glaucoma is characterized by the dysfunction and loss of retinal gangli... (Source: SafetyLit)
Source: SafetyLit - April 4, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Retinal-related blindness imposes high economic burden in Brazil
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news

Diabetes type 2: Glaucoma result of high blood sugar levels and may lead to blindness
DIABETES type 2 has the ability to affect almost every body part, hence the need for a person to safely manage this condition by monitoring their blood sugar levels and eating correctly. Failing to do this could result in blindness, warn healthcare professionals. (Source: Daily Express - Health)
Source: Daily Express - Health - March 30, 2021 Category: Consumer Health News Source Type: news

An efficacy and safety study of intra-arterial recanalization of occluded ophthalmic arteries in patients with monocular blindness caused by injection of hyaluronic acid in facial tissues - Wang J, Shen H, Liu T, Li Q, Lyu Z, Yu Y.
PROPOSE: To evaluate the efficacy and safety of recanalizing hyaluronic acid-occluded retinal central artery by intra-arterially infusing hyaluronidase. METHODS: Between December 2015 and December 2016, 30 patients with monocular blindness due to t... (Source: SafetyLit)
Source: SafetyLit - March 30, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Gold dust in your contact lenses could help colour blindness, research shows 
These 'gold dust' particles filter out certain wavelengths of light, so the brain can distinguish between different colours, particularly reds and greens, more easily. (Source: the Mail online | Health)
Source: the Mail online | Health - March 30, 2021 Category: Consumer Health News Source Type: news

Sobrin Receives Research to Prevent Blindness Physician-Scientist Award
Lucia Sobrin, MD, MPH, of the Division of Ophthalmology, won the Physician-Scientist Award from Research to Prevent Blindness (RPB) for her work in identifying genes that influence the risk of developing ocular hypertension after corticosteroid use. (Source: BWH News)
Source: BWH News - March 29, 2021 Category: Hospital Management Source Type: news

CorneaGen CEO transitions to advisory role, new president named
Seattle-based CorneaGen CEO Monty Montoya transitioned to a strategic advisory role, the company confirmed Wednesday. CorneaGen promoted Bernardino “Bernie” Iliakis from chief operating officer to president to lead the biotech, which works to eliminate corneal blindness. Montoya, who founded the company in 2016, has served as its president and CEO until the transition this year. Prior to founding CorneaGen, Montoya was president and CEO of SightLife, a Seattle-based nonprofit and provider of… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 24, 2021 Category: American Health Authors: Megan Campbell Source Type: news

AHA News: Stroke, Blindness, a Heart Transplant – And a Can-Do Spirit
Title: AHA News: Stroke, Blindness, a Heart Transplant – And a Can-Do SpiritCategory: Health NewsCreated: 3/23/2021 12:00:00 AMLast Editorial Review: 3/24/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 24, 2021 Category: Cardiology Source Type: news

AHA News: Stroke, Blindness, a Heart Transplant – And a Can-Do Spirit
TUESDAY, March 23, 2021 (American Heart Association News) -- Hana Hooper went to college with dreams of becoming a veterinarian. She aspired to boost her knowledge of biology and intended to amplify her interest in art. She was 18, and her future... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 23, 2021 Category: General Medicine Source Type: news